Newsmeme!
Discover News you didn't know existed
DUBLIN----Amarin Corporation plc today announced that it has reached agreement with the U.S. Food and Drug Administration under a Special Protocol Assessment for its planned Phase 3 clinical trial of AMR101 in patients with mixed dyslipidemia.
A new way to 'turn off the taps' in the brain and stop a chemical being released in excess amounts -- which can lead to Parkinson's Disease -- has been developed.
The latest work to 'turn off the taps' in the brain and stop a chemical being released in excess amounts which can lead to Parkinson's Disease - was presented at The British Pharmacological Society's Summer Meeting in Edinburgh.
Washington, July 9 : University of Granada researchers in Spain are using a novel technique, consisting of the induction of neuronal degeneration, for intense light exposure in the mouse's retina, an experimental model of retinitis pigmentosa (RP).
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation , today announced that it has enhanced its capabilities with respect to processing and analysis of medical images for central nervous system and oncology related clinical trials through an alliance with Biospective, Inc.
The latest work to 'turn off the taps' in the brain and stop a chemical being released in excess amounts – which can lead to Parkinson's Disease – will be presented at The British Pharmacological Society's Summer Meeting in Edinburgh today (Wednesday, 8 July 2009).Dr Susan Duty from King's College London will present her latest work, aimed at stimulating 'trigger points' to stop the release of a ...
Scientists use a new technique consisting of the induction of neuronal degeneration for intense light exposure in the mouse’s retina, an experimental model of retinitis pigmentosa.
Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse's retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world.
The latest work to 'turn off the taps' in the brain and stop a chemical being released in excess amounts - which can lead to Parkinson's Disease - will be presented at The British Pharmacological Society's Summer Meeting in Edinburgh today (Wednesday, 8 July 2009).
DUBLIN----Amarin Corporation plc announced today that on July 6, 2009, the Company received a written notification from the Nasdaq Stock Market stating that it is not in compliance with the filing requirements for continued listing under Nasdaq Marketplace Rule 5250.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |